Pain Avoidance Behavior and Its Relation to Risk for Opioid Use in Chronic Pain Patients

NACompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

August 15, 2020

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions
Chronic PainOpioid Use
Interventions
DIAGNOSTIC_TEST

Electroencephalography (EEG)/Magnetoencephalography (MEG)/MRI

This cross-sectional study will present the participants with an instrumental pain avoidance learning task, while we record continuous Magnetoencephalography (MEG) brain signals, and other autonomic measurements. All patients will complete behavioral, neuropsychological and pain assessments to rate their current pain, disability, fear, anxiety, and depression using standardized scales.

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

The Cleveland Clinic

OTHER

NCT04603417 - Pain Avoidance Behavior and Its Relation to Risk for Opioid Use in Chronic Pain Patients | Biotech Hunter | Biotech Hunter